MY8700934A - Pharmaceutical compositions comprising 7,8-dihydroxy-i(hydroxyphenyl)-2,3,4,5-tetrahydro-ih-3-benzazepine derivatives and a beta-adrenergic blocking compound - Google Patents

Pharmaceutical compositions comprising 7,8-dihydroxy-i(hydroxyphenyl)-2,3,4,5-tetrahydro-ih-3-benzazepine derivatives and a beta-adrenergic blocking compound

Info

Publication number
MY8700934A
MY8700934A MY934/87A MY8700934A MY8700934A MY 8700934 A MY8700934 A MY 8700934A MY 934/87 A MY934/87 A MY 934/87A MY 8700934 A MY8700934 A MY 8700934A MY 8700934 A MY8700934 A MY 8700934A
Authority
MY
Malaysia
Prior art keywords
tetrahydro
dihydroxy
hydroxyphenyl
beta
adrenergic blocking
Prior art date
Application number
MY934/87A
Other languages
English (en)
Inventor
Ackerman Dennis Marvin
Berkowitz Barry Alan
Wiebelhaus Virgil Daniel
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of MY8700934A publication Critical patent/MY8700934A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
MY934/87A 1981-12-08 1987-12-30 Pharmaceutical compositions comprising 7,8-dihydroxy-i(hydroxyphenyl)-2,3,4,5-tetrahydro-ih-3-benzazepine derivatives and a beta-adrenergic blocking compound MY8700934A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP81110252A EP0081006B1 (en) 1981-12-08 1981-12-08 Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound

Publications (1)

Publication Number Publication Date
MY8700934A true MY8700934A (en) 1987-12-31

Family

ID=8188060

Family Applications (1)

Application Number Title Priority Date Filing Date
MY934/87A MY8700934A (en) 1981-12-08 1987-12-30 Pharmaceutical compositions comprising 7,8-dihydroxy-i(hydroxyphenyl)-2,3,4,5-tetrahydro-ih-3-benzazepine derivatives and a beta-adrenergic blocking compound

Country Status (18)

Country Link
US (1) US4469690A (pt)
EP (1) EP0081006B1 (pt)
JP (1) JPS58105921A (pt)
AT (1) ATE15762T1 (pt)
AU (1) AU550892B2 (pt)
CA (1) CA1183777A (pt)
DE (1) DE3172458D1 (pt)
GR (1) GR77842B (pt)
HK (1) HK11489A (pt)
HU (1) HU187804B (pt)
IL (1) IL67310A (pt)
MY (1) MY8700934A (pt)
NZ (1) NZ202510A (pt)
PH (1) PH22073A (pt)
PT (1) PT75915B (pt)
SG (1) SG61188G (pt)
ZA (1) ZA829004B (pt)
ZW (1) ZW25482A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0365134A1 (en) * 1988-09-16 1990-04-25 Smithkline Beecham Corporation Synergistic compositions of renal dopaminergic agent and angiotensin converting enzyme inhibitors
EP0476156B1 (en) * 1990-04-06 1996-08-07 Eisai Co., Ltd. Solid oral preparation containing catechol compound
EP1079859B1 (en) 1998-05-22 2010-07-14 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US7022342B2 (en) 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011319A (en) * 1975-07-02 1977-03-08 Smithkline Corporation Pharmaceutical compositions and methods involving benzazepine derivatives
DE2638716A1 (de) * 1976-08-27 1978-03-02 Ici Gmbh Antihypertensiva
US4160765A (en) * 1976-11-17 1979-07-10 Smithkline Corporation Method for 6-bromination of 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
US4171359A (en) * 1978-04-12 1979-10-16 Smithkline Corporation Benz-tetrasubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4265889A (en) * 1978-05-05 1981-05-05 Smithkline Corporation 6-Lower alkyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4192297A (en) * 1978-05-25 1980-03-11 Leopold Labrecque Therapeutic feet bathing device
DE2850078A1 (de) * 1978-11-18 1980-05-29 Basf Ag Aminopropanolderivate des 6-hydroxy-2,3,4,5-tetrahydro-1h-1- benzazepin-2-ons
DE3065940D1 (en) * 1979-07-10 1984-01-26 Smithkline Beckman Corp Synergistic antihypertensive compositions

Also Published As

Publication number Publication date
DE3172458D1 (en) 1985-10-31
AU550892B2 (en) 1986-04-10
HK11489A (en) 1989-02-17
ZW25482A1 (en) 1983-02-23
JPS58105921A (ja) 1983-06-24
US4469690A (en) 1984-09-04
NZ202510A (en) 1985-09-13
GR77842B (pt) 1984-09-25
EP0081006B1 (en) 1985-09-25
HU187804B (en) 1986-02-28
EP0081006A1 (en) 1983-06-15
PH22073A (en) 1988-05-20
SG61188G (en) 1989-07-07
CA1183777A (en) 1985-03-12
AU9084482A (en) 1983-06-16
IL67310A (en) 1988-09-30
ATE15762T1 (de) 1985-10-15
PT75915A (en) 1982-12-01
PT75915B (en) 1985-11-15
ZA829004B (en) 1983-09-28

Similar Documents

Publication Publication Date Title
IT8421343A0 (it) Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti.
OA08481A (fr) Dérivés d'indolizine, leur procédé de préparation ainsi que les compositions les contenant.
DE3366494D1 (de) New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
MY8700934A (en) Pharmaceutical compositions comprising 7,8-dihydroxy-i(hydroxyphenyl)-2,3,4,5-tetrahydro-ih-3-benzazepine derivatives and a beta-adrenergic blocking compound
ES515104A0 (es) "procedimiento para la preparacion de nuevos derivados de pirimidina o s-triacina".
CA1251462C (pt)
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
AR240930A1 (es) "derivados de p-clorofenil-2-furanil-metilen-triazol, intermediarios para su preparacion, procedimientos para la preparacion de dichos compuestos e intermediarios y composiciones fungicidas que contienen a dichos compuestos."
ES513672A0 (es) "procedimiento para la preparacion de derivados de penem".
ES516603A0 (es) "procedimiento para la preparacion de resinas epoxidicas avanzadas".
IL72188A (en) 7-piperidino-1,2,3,5-tetrahydroimidazo(2,1-b)-quinazolin-2-one and salts thereof,their preparation and pharmaceutical compositions containing them
ES509761A0 (es) "procedimiento para la preparacion de 1,2 benzisoxazoloxietilaminas".
GB1511196A (en) Creatinine pyrolidonecarboxylate
EP0087161A3 (en) Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament
ES514224A0 (es) "procedimiento para la preparacion de 2,4-diamino-(3,5-dimetoxi-4-metoxietoxibenzil)-pirimidina".
ES514844A0 (es) "procedimiento para la preparacion de derivados de 5(6)-fenil-sulfoniloxi-bencimidazol".
ES518725A0 (es) Procedimiento de preparacion de nuevos derivados del azabiciclo (3.2.0) heptano.
ES516069A0 (es) "procedimiento para la preparacion de derivados de 1,2,3-tiadiazol-5-il-urea".
FI853506A0 (fi) Nya antibioter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner.
ES515801A0 (es) "procedimiento para la preparacion de derivados de 1,2,3-tiadiazol-5-il-urea".
NO161856C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,4-diamino-1,2,5-tiadiazol-derivater.
IT8420686A1 (it) "procedimenti per la preparazione di derivati del bis-idrossietilmercapto-1,10 - decano"/
ES512940A0 (es) "procedimiento para la preparacion de colorantes azo-estilbenicos".
ATE18994T1 (de) Neue pharmazeutische zusammensetzung.
IT8119606V0 (it) Gassosa limonata con l'aggiunta di liquirizia.